Show simple item record

QUARTZ II-III: Final Efficacy and Safety Results in Patients with HCV Genotype 2 or 3 Infection Treated With Ombitasvir/Paritaprevir/Ritonavir and Sofosbuvir With or Without Ribavirin

dc.contributor.authorShafran, Sen_US
dc.contributor.authorShaw, Den_US
dc.contributor.authorCharafeddine, Men_US
dc.contributor.authorAgarwal, Ken_US
dc.contributor.authorFoster, GRen_US
dc.contributor.authorAbunimeh, Men_US
dc.contributor.authorFu, Ben_US
dc.contributor.authorPilot-Matias, Ten_US
dc.contributor.authorPothacamury, RKen_US
dc.contributor.authorCohen, Een_US
dc.contributor.authorCohen, DEen_US
dc.contributor.authorGane, EJen_US
dc.date.accessioned2017-05-17T11:27:07Z
dc.date.issued2016-10en_US
dc.date.submitted2017-01-04T08:26:34.934Z
dc.identifier.issn0270-9139en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/23142
dc.description.sponsorshipAmer Assoc Study Liver Disen_US
dc.format.extent440A - 440Aen_US
dc.language.isoenen_US
dc.titleQUARTZ II-III: Final Efficacy and Safety Results in Patients with HCV Genotype 2 or 3 Infection Treated With Ombitasvir/Paritaprevir/Ritonavir and Sofosbuvir With or Without Ribavirinen_US
dc.typeConference Proceeding
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493802152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume64en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record